SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Selecta Biosciences, Inc. Receives $3 Million from National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) to Develop Nicotine Vaccine for Smoking Cessation